129 related articles for article (PubMed ID: 17197181)
41. Design, synthesis, and biological evaluation of 16-substituted 4-azasteroids as tissue-selective androgen receptor modulators (SARMs).
Mitchell HJ; Dankulich WP; Hartman GD; Prueksaritanont T; Schmidt A; Vogel RL; Bai C; McElwee-Witmer S; Zhang HZ; Chen F; Leu CT; Kimmel DB; Ray WJ; Nantermet P; Gentile MA; Duggan ME; Meissner RS
J Med Chem; 2009 Aug; 52(15):4578-81. PubMed ID: 19606870
[TBL] [Abstract][Full Text] [Related]
42. Comparative effects of chlormadinone acetate and its 3alpha- and 3beta-hydroxy metabolites on progesterone, androgen and glucocorticoid receptors.
Schneider J; Kneip C; Jahnel U
Pharmacology; 2009; 84(2):74-81. PubMed ID: 19590256
[TBL] [Abstract][Full Text] [Related]
43. Syntheses and structure-activity relationships of novel, potent, and selective trans-2-[3-oxospiro[isobenzofuran-1(3H),1'-cyclohexan]-4'-yl]benzimidazole NPY Y5 receptor antagonists.
Ogino Y; Ohtake N; Nagae Y; Matsuda K; Ishikawa M; Moriya M; Kanesaka M; Mitobe Y; Ito J; Kanno T; Ishihara A; Iwaasa H; Ohe T; Kanatani A; Fukami T
Bioorg Med Chem Lett; 2008 Sep; 18(18):4997-5001. PubMed ID: 18752943
[TBL] [Abstract][Full Text] [Related]
44. Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction.
Cowart M; Latshaw SP; Bhatia P; Daanen JF; Rohde J; Nelson SL; Patel M; Kolasa T; Nakane M; Uchic ME; Miller LN; Terranova MA; Chang R; Donnelly-Roberts DL; Namovic MT; Hollingsworth PR; Martino BR; Lynch JJ; Sullivan JP; Hsieh GC; Moreland RB; Brioni JD; Stewart AO
J Med Chem; 2004 Jul; 47(15):3853-64. PubMed ID: 15239663
[TBL] [Abstract][Full Text] [Related]
45. Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity.
Martin MW; Newcomb J; Nunes JJ; Boucher C; Chai L; Epstein LF; Faust T; Flores S; Gallant P; Gore A; Gu Y; Hsieh F; Huang X; Kim JL; Middleton S; Morgenstern K; Oliveira-dos-Santos A; Patel VF; Powers D; Rose P; Tudor Y; Turci SM; Welcher AA; Zack D; Zhao H; Zhu L; Zhu X; Ghiron C; Ermann M; Johnston D; Saluste CG
J Med Chem; 2008 Mar; 51(6):1637-48. PubMed ID: 18278858
[TBL] [Abstract][Full Text] [Related]
46. Re: androgen receptor antagonism by the organophosphate insecticide fenitrothion.
Goodman JI
Toxicol Sci; 2001 Jul; 62(1):183. PubMed ID: 11399807
[No Abstract] [Full Text] [Related]
47. Pharmacodynamics of selective androgen receptor modulators.
Yin D; Gao W; Kearbey JD; Xu H; Chung K; He Y; Marhefka CA; Veverka KA; Miller DD; Dalton JT
J Pharmacol Exp Ther; 2003 Mar; 304(3):1334-40. PubMed ID: 12604714
[TBL] [Abstract][Full Text] [Related]
48. Benzimidazole CB2 agonists: design, synthesis and SAR.
Nanda KK; Henze DA; Della Penna K; Desai R; Leitl M; Lemaire W; White RB; Yeh S; Brouillette JN; Hartman GD; Bilodeau MT; Trotter BW
Bioorg Med Chem Lett; 2014 Feb; 24(4):1218-21. PubMed ID: 24461289
[TBL] [Abstract][Full Text] [Related]
49. Design, synthesis, and evaluation of novelly substituted benzimidazole compounds as angiotensin II receptor antagonists.
Bali A; Bansal Y; Sugumaran M; Saggu JS; Balakumar P; Kaur G; Bansal G; Sharma A; Singh M
Bioorg Med Chem Lett; 2005 Sep; 15(17):3962-5. PubMed ID: 16039125
[TBL] [Abstract][Full Text] [Related]
50. Antiandrogenic activities of Glycyrrhiza glabra in male rats.
Zamansoltani F; Nassiri-Asl M; Sarookhani MR; Jahani-Hashemi H; Zangivand AA
Int J Androl; 2009 Aug; 32(4):417-22. PubMed ID: 19515171
[TBL] [Abstract][Full Text] [Related]
51. Design, syntheses, and structure-activity relationships of novel NPY Y5 receptor antagonists: 2-{3-Oxospiro[isobenzofuran-1(3H),4'-piperidin]-1'-yl}benzimidazole derivatives.
Ogino Y; Ohtake N; Nagae Y; Matsuda K; Moriya M; Suga T; Ishikawa M; Kanesaka M; Mitobe Y; Ito J; Kanno T; Ishihara A; Iwaasa H; Ohe T; Kanatani A; Fukami T
Bioorg Med Chem Lett; 2008 Sep; 18(18):5010-4. PubMed ID: 18723347
[TBL] [Abstract][Full Text] [Related]
52. Structure-Based Approach To Identify 5-[4-Hydroxyphenyl]pyrrole-2-carbonitrile Derivatives as Potent and Tissue Selective Androgen Receptor Modulators.
Unwalla R; Mousseau JJ; Fadeyi OO; Choi C; Parris K; Hu B; Kenney T; Chippari S; McNally C; Vishwanathan K; Kilbourne E; Thompson C; Nagpal S; Wrobel J; Yudt M; Morris CA; Powell D; Gilbert AM; Chekler ELP
J Med Chem; 2017 Jul; 60(14):6451-6457. PubMed ID: 28696695
[TBL] [Abstract][Full Text] [Related]
53. Recent advances in the development of selective androgen receptor modulators.
Zhang X; Lanter JC; Sui Z
Expert Opin Ther Pat; 2009 Sep; 19(9):1239-58. PubMed ID: 19505196
[TBL] [Abstract][Full Text] [Related]
54. The prohormone 19-norandrostenedione displays selective androgen receptor modulator (SARM) like properties after subcutaneous administration.
Diel P; Friedel A; Geyer H; Kamber M; Laudenbach-Leschowsky U; Schänzer W; Schleipen B; Thevis M; Vollmer G; Zierau O
Toxicol Lett; 2008 Apr; 177(3):198-204. PubMed ID: 18325697
[TBL] [Abstract][Full Text] [Related]
55. In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT(4) receptor.
Mikami T; Komada T; Sugimoto H; Suzuki K; Ohmi T; Kimura N; Naganeo R; Nakata E; Nakatani K; Toga T; Eda H; Sakakibara M
Eur J Pharmacol; 2009 May; 609(1-3):5-12. PubMed ID: 19285067
[TBL] [Abstract][Full Text] [Related]
56. Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors.
Hasegawa M; Nishigaki N; Washio Y; Kano K; Harris PA; Sato H; Mori I; West RI; Shibahara M; Toyoda H; Wang L; Nolte RT; Veal JM; Cheung M
J Med Chem; 2007 Sep; 50(18):4453-70. PubMed ID: 17676829
[TBL] [Abstract][Full Text] [Related]
57. Structure-based design and synthesis of benzimidazole derivatives as dipeptidyl peptidase IV inhibitors.
Wallace MB; Feng J; Zhang Z; Skene RJ; Shi L; Caster CL; Kassel DB; Xu R; Gwaltney SL
Bioorg Med Chem Lett; 2008 Apr; 18(7):2362-7. PubMed ID: 18346892
[TBL] [Abstract][Full Text] [Related]
58. Design, optimization, and biological evaluation of novel keto-benzimidazoles as potent and selective inhibitors of phosphodiesterase 10A (PDE10A).
Hu E; Kunz RK; Chen N; Rumfelt S; Siegmund A; Andrews K; Chmait S; Zhao S; Davis C; Chen H; Lester-Zeiner D; Ma J; Biorn C; Shi J; Porter A; Treanor J; Allen JR
J Med Chem; 2013 Nov; 56(21):8781-92. PubMed ID: 24102193
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and biological evaluation of amino-pyridines as androgen receptor antagonists for stimulating hair growth and reducing sebum production.
Hu LY; Lei HJ; Du D; Johnson TR; Fedij V; Kostlan C; Yue WS; Lovdahl M; Li JJ; Carroll M; Dettling D; Asbill J; Fan C; Wade K; Pocalyko D; Lapham K; Yalamanchili R; Samas B; Vrieze D; Ciotti S; Krieger-Burke T; Sliskovic D; Welgus H
Bioorg Med Chem Lett; 2007 Oct; 17(20):5693-7. PubMed ID: 17766112
[TBL] [Abstract][Full Text] [Related]
60. The SAR studies of novel CB2 selective agonists, benzimidazolone derivatives.
Omura H; Kawai M; Shima A; Iwata Y; Ito F; Masuda T; Ohta A; Makita N; Omoto K; Sugimoto H; Kikuchi A; Iwata H; Ando K
Bioorg Med Chem Lett; 2008 Jun; 18(11):3310-4. PubMed ID: 18440813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
